Skip to content

The Effect of Changing from Isoflurane to Desflurane during the Latter Part of Anaesthesia on the Recovery Profile

The Effect of Changing from Isoflurane to Desflurane during the Latter Part of Anaesthesia on the Recovery Profile in patients undergoing laparotomy: double blinded randomized clincal trial

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12610000013066
Enrollment
103
Registered
2010-01-07
Start date
2008-09-12
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Compared to other currently available inhalational anaesthetics, desflurane is less soluble. Consequently, its rapid elimination from the brain is expected to result in an improved postoperative recovery profile. However, desflurane is more expensive to administer than other inhalational anaesthetics. Isoflurane is a commonly used inhaled volatile anaesthetic because it is relatively inexpensive despite its high solubility. To combine the advantages of rapid emergence from desflurane anaesthesia with the lower cost of a more soluble inhalation anaesthetic, we substitute desflurane with isoflurane during the latter part of anaesthesia and compare the emergence and recovery characteristic with pure desflurane and pure isoflurane anesthesia. We hypothesize the substitution from isoflurane to desflurane during the latter part of anesthesia improve recovery and emergence characteristics.

Interventions

inhaled anaesthesia was maintained with 1.2-2.4 vol% of isoflurane depending on the vital sign to the point when the operation was predicted to end in an hour; subsequently, isoflurane was replaced with 1 minimum alveolar concentration (MAC) of inhaled desflurane (1 MAC of desflurane = 6 vol%) in 1.5 L/min oxygen (O2) and 1.5 L/min nitrous oxide (N2O)

Sponsors

Chung-Ang University
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used)

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

patients undergoing laparotomy expected to lasting 3 or more hours under general anaesthesia

Exclusion criteria

Patients with clinically significant pulmonary, cardiovascular, hepatic, renal, hematologic, neurologic, or metabolic diseases and those who were chronic users of drugs that are known to affect anaesthetic requirements

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026